Yet, disinhibition of these PER2-dependent glycolytic genes nevertheless sufficiently reprograms the SE landscape of these genes to sustain a metabolic dependency in this subset of lung cancer with increased sensitivity to glycolysis inhibiton [18]. The gene discussed is PER2; the disease is lung cancer.